PLAY PODCASTS
Conference Conversations: HIV Advanced Practice Provider Perspectives from CROI 2022
Episode 148

Conference Conversations: HIV Advanced Practice Provider Perspectives from CROI 2022

Listen to expert insights from Jeffrey Kwong, DNP, MPH, FAANP, FAAN, and Susan LeLacheur, DrPH, PA-C, AAHIVS, as they discuss new data presented at CROI 2022, including key findings on perinatal ART exposure, an investigational formulation for the prevention of pregnancy and HIV, monitoring requirements in LA CAB for PrEP, and myocardial infarction risk in PWH.

Decera Clinical Education Infectious Disease Podcast · Jeffrey Kwong DNP MPH FAANP FAAN, Susan LeLacheur DrPH PA-C AAHIVS

March 16, 202218m 10s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Jeffrey Kwong, DNP, MPH, FAANP, FAAN, and Susan LeLacheur, DrPH, PA-C, AAHIVS, share insights on new HIV data from CROI 2022, including:

  • Perinatal antiretroviral therapy exposure
  • Investigational formulation of long-acting contraception combined with pre-exposure prophylaxis
  • Monitoring with long-acting cabotegravir for pre-exposure prophylaxis
  • Myocardial infarction risk by HIV status

Presenters:

Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Professor
Division of Advanced Nursing Practice
Rutgers School of Nursing
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Susan LeLacheur, DrPH, PA-C, AAHIVS
Professor
PA Studies
The George Washington University School of Medicine and Health Sciences
Washington, DC

Link to full program:  
https://bit.ly/3tdkXfJ


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

hiv and pregnancycabotegravircombination contraception and prepcabinfant birth weightlong-acting artmyocardial infarction and hivperinatal art exposurematernal weight gainmedroxyprogesterone acetatedtglong-acting cabotegravirisfuinsti resistancela cabin situ-forming implantprepperinatal arv exposurerammi riskimpaact 2010efvresistanceetonogestrelhiv-1 rna testperinatal hivmutationsresistance-associated mutationsarthiv